Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Breast 8Lymphoid 6Genitourinary 6Gastrointestinal 6Tumor-Agnostic 5Thoracic 4Plasma cell 4Other solid neoplasm 4Head & Neck 4Gynecologic 4CNS 2Sarcoma 1Myeloid 1Dermatologic 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 54Specimen Handling 50Magnetic Resonance Spectroscopy 49pembrolizumab 43Doxorubicin 43Radiotherapy 42Temozolomide 37Biopsy 34Radiation 29Nivolumab 28fludarabine 23Vincristine 22Irinotecan 21Gemcitabine 21X-Rays 20Surgical Procedures, Operative 19Ifosfamide 19atezolizumab 17cabozantinib 15Ipilimumab 15olaparib 13Sunitinib 13Paclitaxel 13regorafenib 12fludarabine phosphate 12Phantoms, Imaging 12Imatinib Mesylate 12Etoposide 12Blood Specimen Collection 12Carboplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Palliative Care × Sarcoma × 1 year × Clear all
NCT04593277 2026-01-23

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

Fred Hutchinson Cancer Center

Phase NA Completed
549 enrolled
GastrointestinalHead & NeckLymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Sarcoma, Thyroid Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡